Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
VOX.WA
Strong BuyFull HouseVoxel S.A. · Healthcare · Poland · $374M · Avg Vol: $447K/d
COMPANY DESCRIPTION
Voxel S.A. is a leading provider of diagnostic imaging services in Poland, operating a nationwide network of magnetic resonance (MRI), computed tomography (CT), and positron emission tomography (PET) centers. The company also manufactures radiopharmaceuticals and provides specialized IT solutions for medical facilities. Its competitive moat is built on its dominant market position in high-end diagnostics, long-term public healthcare contracts, and advanced technological infrastructure.
FINANCIAL SUMMARY (PLN)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 360.6M | 424.2M | 507.8M | 583.8M | 17.4% | 583.2M | 598.0M | 623.5M | 3.3% |
| EPS (PLN) | 5.17 | 7.70 | 9.20 | 9.40 | 22.1% | 37.47 | 9.16 | 9.57 | 0.9% |
| Shares | 10.5M | 10.5M | 10.5M | 10.5M | 0.0% | 10.5M | — | — | — |
| Debt | 138.5M | 127.1M | 126.9M | 185.6M | 10.3% | 196.4M | — | — | — |
| Equity | 241.9M | 293.3M | 360.6M | 408.9M | 19.1% | — | — | — | — |
| Op CF | 96.2M | 129.0M | 122.3M | 116.7M | 6.6% | 137.9M | — | — | — |
| Inv CF | -30.5M | -39.6M | -69.4M | -103.2M | — | — | — | — | — |
| Fin CF | -86.7M | -58.4M | -64.2M | -53.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of VOX.WA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| VOX.WA | Voxel S.A.(you) | $374M | 88 | Strong Buy |
| DIA.WA | Diagnostyka S.A. | $1.5B | 81 | Strong Buy |
| SLV.WA | Selvita S.A. | $132M | 40 | Hold |
| SCP.WA | Scope Fluidics S.A. | $116M | 11 | Strong Sell |
| NEU.WA | NEUCA S.A. | $953M | 84 | Strong Buy |
| MRC.WA | Mercator Medical S.A. | $143M | 73 | Buy |
| SNT.WA | Synektik Spólka Akcyjna | $763M | 64 | Hold |
| CLN.WA | Celon Pharma S.A. | $231M | 46 | Hold |
| BIO.WA | BIOTON S.A. | $87M | 51 | Hold |
| ICE.WA | Medinice S.A. | $200M | 25 | Sell |
Peer medians: ROE -19.0% · P/E 18.1x · Gross margin 32.3%